SCHEMBL7074007

SCHEMBL7074007

CCCOc1c(C(=O)O)oc2ccc(OC)cc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 13/20 0.54
ALDH1A1 P00352 10/20 0.51
HPGD P15428 6/20 0.50
HSD17B10 Q99714 4/20 0.50
SMN1; SMN2 Q16637 10/20 0.49
TP53 P04637 1/20 0.49
HTT P42858 1/20 0.49
NPC1 O15118 9/20 0.48
RAB9A P51151 9/20 0.48
MAPT P10636 4/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
MEN1 O00255 2/20 0.47
LMNA P02545 2/20 0.47
KMT2A Q03164 2/20 0.47
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7001218 0.90 KDM4E (0.64) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL10870541 0.89 KDM4E (0.61) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL7076857 0.86 GAA (0.56) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL6234986 0.85 KDM4E (0.61) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL5735830 0.84 KDM4E (0.49) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL5733297 0.83 NPC1 (0.47) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL5733474 0.83 NPC1 (0.48) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL9433280 0.82 ANO1 (0.54) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5733487 0.81 KDM4E (0.51) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL5734369 0.81 RAB9A (0.49) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1320523-A2 BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES Warner-Lambert Company LLC (US) 2003-06-25 EP disclosed
WO-2002024672-A2 BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES WARNER-LAMBERT COMPANY LLC (US) 2002-03-28 WO disclosed